Navigation Links
Stopping Daily Aspirin Boosts Heart Attack Risk: Study
Date:7/20/2011

By Steven Reinberg
HealthDay Reporter

TUESDAY, July 19 (HealthDay News) -- People with heart disease who stop taking their daily low-dose aspirin may put themselves at a greater risk of having a heart attack, a new study finds.

Aspirin taken daily in a low dose (typically between 75 and 300 milligrams) is recommended to help prevent blood clots in patients with heart disease. Yet as many as 50 percent of patients stop taking their aspirin, the researchers noted. This can result in an increased risk of heart problems, but little is known about whether there is an increased risk for heart attack specifically.

The new study suggests heart attack risk does rise when low-dose aspirin is discontinued. Therefore, patients "should be advised that unless there is a high risk of serious bleeding or otherwise recommended by a doctor, aspirin should never be discontinued given its overwhelming benefits," said lead researcher Dr. Luis Garcia Rodriguez, director of the Spanish Center for Pharmacoepidemiologic Research in Madrid.

"Also, patients who need to discontinue aspirin should do so for the minimum time necessary," he added.

The report was published in the July 19 online edition of the BMJ.

For the study, Rodriguez's team collected data on more than 39,500 patients, 50 to 84 years of age, who were part of the Health Improvement Network -- a large database of medical records in the United Kingdom.

Between 2000 and 2007, the patients were prescribed low-dose aspirin (75 to 300 milligrams per day) to prevent heart attack and other cardiac complications.

Over about 3 years of follow-up, Garcia Rodriguez's team found that those who stopped taking aspirin experienced a 60 percent rise in their risk of non-fatal heart attack. That result held true regardless of how long the patients had taken aspirin before they decided to stop.

According to the researchers, the finding translates into four additional heart attacks for every 1,000 patients during the year they stopped taking their aspirin.

"Our study highlights the need for greater awareness of the increased risk of cardiovascular events, such as [heart attack], that is associated with interruption of aspirin therapy," Garcia Rodriguez said.

"If adherence to low-dose aspirin could be improved, the benefit obtained with low-dose aspirin in the general population would be increased," he added.

Dr. Giuseppe Biondi-Zoccai, assistant professor of cardiology at the University of Modena and Reggio Emilia in Modena, Italy, and co-author of an accompanying journal editorial, said that "aspirin is indeed a wonderful drug."

Low-dose aspirin reduces illness and death from heart disease, pulmonary embolism (clots in the lung) and colorectal cancer, he said. It is also remarkably safe, if one avoids it in those at risk of allergic or bleeding complications, and it is cheap, which is also a major plus.

In addition, aspirin helps prevent recurrent events in patients who have already suffered from coronary artery disease, Biondi-Zoccai, said.

"Discontinuing aspirin in such patients is very harmful," he added. "Indeed, patients on aspirin, because they have already suffered from a coronary artery event, face a major health hazard if aspirin is discontinued, even only temporarily, and even if several months or years have passed from their initial heart problem."

Another expert, Dr. Gregg C. Fonarow, a professor of cardiology at the University of California, Los Angeles, agreed.

"While aspirin use can increase the risk of bleeding, for most patients with known vascular disease the benefits of daily low dose aspirin exceed the potential risks," he said. "Individuals with cardiovascular disease should understand the benefits of long term aspirin use and that discontinuing their aspirin regimen places them at increased risk for subsequent cardiovascular events. Patients should not discontinue aspirin therapy unless under the advice of their physician to do so."

More information

For more information on heart disease and aspirin, visit the American Heart Association.

SOURCES: Luis Garcia Rodriguez, M.D., director, Spanish Centre for Pharmacoepidemiologic Research, Madrid, Spain; Giuseppe Biondi-Zoccai, M.D., assistant professor of cardiology, University of Modena and Reggio Emilia, Modena, Italy; Gregg C. Fonarow, M.D., professor, cardiology, University of California, Los Angeles; July 19, 2011, BMJ, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. ACP commends Congress for preserving patient access by stopping scheduled Medicare SGR cuts
2. Internists issue heartfelt plea for Congress to help patients by stopping Medicare SGR cuts
3. Researchers find new target for stopping tumors developing their own blood supply
4. Stopping smoking cessation treatments too soon may reduce odds of success for 45 percent of smokers
5. Non-IV-administered medication just as effective in stopping seizures
6. The Infrex Plus is Revolutionizing Pain Control by Stopping Pain & Eliminating Drugs for Chronic Pain Patients Who Suffered For Years
7. Higher daily dose of aspirin could play key role in preventing heart attacks for those with diabetes
8. Snacking Totals a Quarter of Daily Calories for Many
9. Daily Four-Drug Combo Pill Halves Heart Disease Risk: Study
10. Researchers observe disruptions of daily rhythms in Alzheimers patients brains
11. New ACE survey shows people with type 2 diabetes experience low blood sugar during typical daily activities
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stopping Daily Aspirin Boosts Heart Attack Risk: Study 
(Date:12/2/2016)... ... ... years, Doctors on Liens has published a directory of the top doctors working ... When the company started in 1997, the directory was a single page focusing on chiropractors ... directory features a vast array of medical specialists stretching from Sacramento to San ...
(Date:12/2/2016)... ... December 02, 2016 , ... Center for Autism and ... of those affected by autism spectrum disorder (ASD) and other developmental disabilities. The group, ... will give parents and other caregivers the opportunity to share stories and advice, seek ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s newest campaign, ... standing as living proof that attitude and determination can combine into the most ... spike around the holidays. This campaign will offer patients a new-found hope, by ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research ... labeling, storing, shipping and disposal. The new version is a faster and a ...
(Date:12/2/2016)... Wexford, PA (PRWEB) , ... December 02, 2016 , ... ... manages stress and overall health, day and night. No other wearable health technology on ... management. We wanted to give poeple more meaningful insights about their health than ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016  LifeVac, the revolutionary ... included in the Emergency Response Training and Support Services ... excited to have LifeVac become part of the ERTSS ... Founder and CEO of LifeVac. "Having an established network ... and effectively will help leverage our efforts to spread ...
(Date:12/2/2016)... -- PipelineRx, a leading medication management technology company focused ... its SaaS-based telepharmacy platform, PowerGridRx™ , at ... Clinical Meeting and Exhibition, December 5-7 in ... hospital clients nationally, the Company is a leader ... improve pharmacy operations, enhance patient safety, and reduce ...
(Date:12/2/2016)... 2, 2016  Maxor National Pharmacy Services, LLC ("Maxor"), today ... Inc. ("PSI").  The combination of Texas -based ... -based PSI bring together both company,s clinical expertise and high-touch ... an industry-leading specialty pharmacy. About Maxor ... , , ...
Breaking Medicine Technology: